FDA.reportPublic FDA data

Miracle Plus Diabetic Homeopathic

Manufacturer
Concept Laboratories, Inc. | HomeoCare Laboratories Inc
Effective date
2019-11-15
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 02:11:34

Label at a glance#

ProductMiracle Plus Diabetic Homeopathic Nerve Pain Reliever
Active ingredientACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM SPORE, PHOSPHORUS, TOXICODENDRON PUBESCENS LEAF, CLAVICEPS PURPUREA SCLEROTIUM
Label structure10 sections

Indications and uses

temporary relieves symptoms of nerve pain, such as burning, shooting, tingling and stabbing pain.

Dosage and administration

Apply a small amount to the affected area. Use no more than 4 times daily.

Storage and handling

Store at room temperature 59–86°F (15–30°C).

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Aconitum napellus 12C, Hypericum perfoliatum 12C, Lycopodium clavatum 12C, Phosphorus 12C, Rhus toxicodendron 12C, Secale cornutum 12C

Purpose

OTC - PURPOSE SECTION

Topical analgesic

Uses

INDICATIONS & USAGE SECTION

temporary relieves symptoms of nerve pain, such as burning, shooting, tingling and stabbing pain.

Warnings

WARNINGS SECTION

  • For topical use only.

OTC - WHEN USING SECTION

  • Avoid contact with eyes and mucuos membranes.

OTC - DO NOT USE SECTION

  • Do not use on broken skin.
  • Strong floral aroma.

OTC - STOP USE SECTION

  • Discontinue use if skin irritation develops. Shooting, burning pain in the toes and hands can be signs of diabetic neuropathy.

OTC - ASK DOCTOR SECTION

See a health care professional on a regular basis if you are diabetic, or if you suspect you are diabetic.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

  • Keep out of reach of children.

OTC - WHEN USING SECTION

When using this product Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

Directions

DOSAGE & ADMINISTRATION SECTION

Apply a small amount to the affected area. Use no more than 4 times daily.

Other information

STORAGE AND HANDLING SECTION

Store at room temperature 59–86°F (15–30°C).

Other ingredients

INACTIVE INGREDIENT SECTION

Safflower Oil, Apricot Oil, Avocado Oil, Essential Oils of Tea Tree, Lavender, Eucalyptus, Geranium, Bergamot, Polysorbate 20.

SPL UNCLASSIFIED SECTION

Distributed by Concept Laboratories, Inc., Chicago, IL 60642 www.conceptlabs.org

PRINCIPAL DISPLAY PANEL - 5 mL Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Miracle Plus ®

Diabetic Homeopathic Nerve Pain Reliever

0.17 fl oz (5 ml)

Principal Display Panel - 5 mL Bottle Label
Principal Display Panel - 5 mL Bottle Label

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
64058-145-212022-01-28C16284748780-1d6a99b39-50f5-a426-e053-dadaa90af4c2Miracle Plus ® Diabetic Homeopathic Nerve Pain Reliever

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
64058-145-21Miracle Plus Diabetic HomeopathicNerve Pain Reliever5 mL in 1 BOTTLELIQUID52

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
64058-145MIRACLE PLUS DIABETIC HOMEOPATHIC NERVE PAIN RELIEVER (ACONITUM NAPELLUS, HYPERICUM PERFORATUM, LYCOPODIUM CLAVATUM SPORE, PHOSPHORUS, TOXICODENDRON PUBESCENS LEAF, AND CLAVICEPS PURPUREA SCLEROTIUM) LIQUID [CONCEPT LABORATORIES, INC.]2Legacy NDC, 1 package rows20191116_aed9fa91-1d21-4da4-8965-ea0011074ba1.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ACONITUM NAPELLUSACTIVE INGREDIENTU0NQ8555JD1
CLAVICEPS PURPUREA SCLEROTIUMACTIVE INGREDIENT01G9XEA93N1
HYPERICUM PERFORATUMACTIVE INGREDIENTXK4IUX8MNB1
LYCOPODIUM CLAVATUM SPOREACTIVE INGREDIENTC88X29Y4791
PHOSPHORUSACTIVE INGREDIENT27YLU75U4W1
TOXICODENDRON PUBESCENS LEAFACTIVE INGREDIENT6IO182RP7A1
ACONITUM NAPELLUSACTIVE MOIETYU0NQ8555JD1
CLAVICEPS PURPUREA SCLEROTIUMACTIVE MOIETY01G9XEA93N1
HYPERICUM PERFORATUMACTIVE MOIETYXK4IUX8MNB1
LYCOPODIUM CLAVATUM SPOREACTIVE MOIETYC88X29Y4791
PHOSPHORUSACTIVE MOIETY27YLU75U4W1
TOXICODENDRON PUBESCENS LEAFACTIVE MOIETY6IO182RP7A1
APRICOT KERNEL OILINACTIVE INGREDIENT54JB35T06A1
AVOCADO OILINACTIVE INGREDIENT6VNO72PFC11
BERGAMOT OILINACTIVE INGREDIENT39W1PKE3JI1
EUCALYPTUS OILINACTIVE INGREDIENT2R04ONI6621
GERANIUM OIL, ALGERIAN TYPEINACTIVE INGREDIENT5Q1I94P4WG1
LAVENDER OILINACTIVE INGREDIENTZBP1YXW0H81
POLYSORBATE 20INACTIVE INGREDIENT7T1F30V5YH1
SAFFLOWER OILINACTIVE INGREDIENT65UEH262IS1
TEA TREE OILINACTIVE INGREDIENTVIF565UC2G1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
64058-14564058-145-21

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Name, UNII, Kind table
NameUNIIKind
POLYSORBATE 207T1F30V5YHIACT
ACONITUM NAPELLUSU0NQ8555JDACTIB
HYPERICUM PERFORATUMXK4IUX8MNBACTIB
LYCOPODIUM CLAVATUM SPOREC88X29Y479ACTIB
PHOSPHORUS27YLU75U4WACTIB
TOXICODENDRON PUBESCENS LEAF6IO182RP7AACTIB
CLAVICEPS PURPUREA SCLEROTIUM01G9XEA93NACTIB
SAFFLOWER OIL65UEH262ISIACT
APRICOT KERNEL OIL54JB35T06AIACT
AVOCADO OIL6VNO72PFC1IACT
TEA TREE OILVIF565UC2GIACT
LAVENDER OILZBP1YXW0H8IACT
EUCALYPTUS OIL2R04ONI662IACT
GERANIUM OIL, ALGERIAN TYPE5Q1I94P4WGIACT
BERGAMOT OIL39W1PKE3JIIACT

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 32 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
POLYSORBATE 20POLYSORBATE 207T1F30V5YHINJECTION / SUBCUTANEOUSNAExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHINJECTION / INTRAMUSCULAR1.62 %w/vExact identifier — unii candidate
28 equally ranked IID candidates
SAFFLOWER OILSAFFLOWER OIL65UEH262ISLOTION / TOPICAL3510 mgExact identifier — unii candidate
POLYSORBATE 20POLYSORBATE 207T1F30V5YHTAMPON / VAGINAL64.8 mgExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHLOTION / TOPICAL2000 mgExact identifier — unii candidate
28 equally ranked IID candidates
LAVENDER OILLAVENDER OILZBP1YXW0H8INHALANT / NASALNAExact identifier — unii candidate
2 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHPOWDER, FOR SUSPENSION / ORAL1.3 mg/5mlExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHSUSPENSION / ORAL80 mgExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHEMULSION / TOPICAL2 %w/wExact identifier — unii candidate
28 equally ranked IID candidates
EUCALYPTUS OILEUCALYPTUS OIL2R04ONI662SYRUP / ORALNAExact identifier — unii candidate
POLYSORBATE 20POLYSORBATE 207T1F30V5YHINJECTION / INTRAVENOUS30 mgExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHTABLET / ORAL17 mgExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHINJECTION, POWDER, FOR SOLUTION / INTRAVENOUSNAExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHAEROSOL, FOAM / TOPICAL3.7 %w/wExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHSPRAY, METERED / NASAL40 mgExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHSUSPENSION / OPHTHALMIC0.05 %w/vExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHINJECTION, SOLUTION / INTRAVENOUS30 mgExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHSHAMPOO / TOPICAL8 %w/wExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHINJECTION, SOLUTION / SUBCUTANEOUSNAExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHGEL / TOPICAL5 %w/wExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHCAPSULE / ORAL563 mgExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHSOLUTION / TOPICAL15 %w/wExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHINJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR60 mgExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHTABLET, FILM COATED / ORAL0.35 mgExact identifier — unii candidate
28 equally ranked IID candidates
LAVENDER OILLAVENDER OILZBP1YXW0H8GEL / TOPICAL0.1 %w/wExact identifier — unii candidate
2 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHSUPPOSITORY / VAGINALNAExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHCLOTH / TOPICALNAExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHSUSPENSION / AURICULAR (OTIC)0.1 %w/vExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHAEROSOL, FOAM / VAGINAL3 %w/wExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHSOAP / TOPICAL0.02 %w/wExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHCREAM / TOPICAL108 mgExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHTABLET, EXTENDED RELEASE / ORAL4.2 mgExact identifier — unii candidate
28 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
976434f8-b77d-a84e-e053-2995a90a5043aed9fa91-1d21-4da4-8965-ea0011074ba12019-11-15WarningsExact identifier
spl id: 976434f8-b77d-a84e-e053-2995a90a5043
spl set id: aed9fa91-1d21-4da4-8965-ea0011074ba1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.